Sponsor
Federico II University
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Federico II University appears in 110 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownGLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DMNCT07314684 · lead sponsor · 2025-09-08
RECRUITINGSusceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"NCT06236932 · lead sponsor · 2023-12-29
RECRUITINGNaples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)NCT06162247 · lead sponsor · 2023-11-20
RECRUITINGGlycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes PeopleNCT06994403 · lead sponsor · 2023-09-04
RECRUITINGCharacterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in ItalyNCT07375069 · lead sponsor · 2022-10-01
RECRUITINGEvaluation of Main Determinants of Postprandial Glucose Response in Type 1 DiabetesNCT05936242 · lead sponsor · 2021-05-18
RECRUITINGRegistro Campania Salute Network on HypertensionNCT02211365 · lead sponsor · 2014-02-01
RECRUITINGCirculating Tumor DNA Dynamics to Optimize Neoadjuvant Therapy in HER2-Positive and Triple-Negative Breast CancerNCT07662252 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGShared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)NCT07578415 · lead sponsor · 2026-06-01
NOT_YET_RECRUITINGImmune Nutrition in Pediatric Respiratory AllergyNCT07308288 · lead sponsor · 2025-06-01
COMPLETEDEffect of Oral L-arginine 3.32 g a Day on Oxidative Stress Influencing Beta Cell Function and Insulin Resistance.NCT06686069 · lead sponsor · 2025-01-18
NOT_YET_RECRUITINGEpivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic RetinopathyNCT07526857 · lead sponsor · 2025-01-01
COMPLETEDEffects of Oral Sodium Butyrate Supplementation on Body Weight Reduction in Overweight/Obese Individuals With and Without Type 2 DiabetesNCT07252609 · lead sponsor · 2024-11-13
COMPLETEDMedium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 DiabetesNCT06895018 · lead sponsor · 2024-05-03
ENROLLING_BY_INVITATIONSNORD3A IN ISCHEMIC HEART DISEASE AND HEART FAILURENCT06678802 · lead sponsor · 2024-03-01
UNKNOWNExercise Training and Rehabilitation In Cardiac AmyloidosisNCT06412432 · lead sponsor · 2024-01-10
UNKNOWNIndividual Determinants of Postprandial Glucose Response in Type 2 DiabetesNCT06057246 · lead sponsor · 2023-05-15
UNKNOWNManagement of Heart Failure in Italian Outpatients Clinics: Observational StudyNCT06287164 · lead sponsor · 2023-03-01
UNKNOWNOCT and OCT-A Deep Learning in Diabetic Patients Wiht Artificial Pancreas DeviceNCT05809843 · lead sponsor · 2023-01-30
COMPLETEDManagement of Prolonged Aerobic exeRcise in Patients With Type 1 Diabetes on Advanced TechnologiesNCT05936203 · lead sponsor · 2023-01-11
COMPLETEDThe UFO (Ultra Processed Foods in Obesity) ProjectNCT05554016 · lead sponsor · 2022-09-01
COMPLETEDTauropace to Prevent Cardiac Implantable Device Infections in Heart Failure PatientsNCT05103267 · lead sponsor · 2022-06-06
UNKNOWNMetabolic Effects of Oral Sodium Butyrate Supplementation on Overweight IndividualsNCT06247020 · lead sponsor · 2022-02-24
COMPLETEDOCTA Study of Choroidal Vasculature in Open Angle Glaucoma PatientsNCT05455567 · lead sponsor · 2022-02-01
COMPLETEDDietary Intervention With Probiotic Pasta and Evaluation of the Effects on Metabolic and Inflammatory StatusNCT04962633 · lead sponsor · 2022-01-01
COMPLETEDPrognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on CirrhosisNCT05800561 · lead sponsor · 2022-01-01
UNKNOWNPlasma SCFAs After Fermentable Cereal Fibres - A Postprandial StudyNCT05443828 · lead sponsor · 2021-11-09
COMPLETEDEffects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the OffspringNCT05119868 · lead sponsor · 2021-11-02
COMPLETEDREal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth TechnologyNCT05175937 · lead sponsor · 2021-09-22
UNKNOWNFiber-enriched Croissant Consumption and Effects on Metabolic Status, Appetite and Gut MicrobiotaNCT04999280 · lead sponsor · 2021-09-01
COMPLETEDIndividualized, Technological Interventions for Diabetes Care in the COVID-19 WardNCT04871958 · lead sponsor · 2021-03-19
TERMINATEDEvaluation of Surgical Complications and DFS in Obese Rectal Cancer PatientsNCT06056726 · lead sponsor · 2021-02-18
UNKNOWNFitostimoline® Hydrogel Versus Saline Gauze Dressing in Diabetic Foot UlcersNCT05661474 · lead sponsor · 2021-02-01
COMPLETEDOCTA in Epivascular Glia After Dex ImplantNCT05600179 · lead sponsor · 2021-01-01
COMPLETEDEffects of Butyrate Against Pediatric ObesityNCT04620057 · lead sponsor · 2020-11-01
COMPLETEDEffects of L-arginine on Myocardial Energetic Efficiency and Global Longitudinal StrainNCT04626375 · lead sponsor · 2020-09-14
COMPLETEDCalorie Restriction in Multiple SclerosisNCT04042415 · lead sponsor · 2020-07-14
UNKNOWNAS-OCT Study in Diabetic RetinopathyNCT04992325 · lead sponsor · 2020-07-01
COMPLETEDGut Microbiome and ObesityNCT04451148 · lead sponsor · 2020-05-01
UNKNOWNEffect of Ketogenic Diet on Peri-operative Complications of Right Laparoscopic Adrenalectomy in Obese PatientsNCT05816031 · lead sponsor · 2020-01-01
UNKNOWNPolyphenol Enriched Extra-virgin Olive Oil and Postprandial Glycemia in Type 1 Diabetes (DOP)NCT04764786 · lead sponsor · 2019-04-01
COMPLETEDTreatment of GHD Associated With CHFNCT03775993 · lead sponsor · 2019-03-01
UNKNOWNEffect of Liraglutide on Microbiome in ObesityNCT04046822 · lead sponsor · 2019-01-09
UNKNOWNPizza Leavening and Postprandial Glycemia in Type 1 Diabetes (LEAVEN)NCT03619031 · lead sponsor · 2018-05-03
COMPLETEDClinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up StudyNCT04375943 · lead sponsor · 2018-04-01
COMPLETEDMetabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast CancerNCT07044791 · lead sponsor · 2018-02-02
ACTIVE_NOT_RECRUITINGEffect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the OffspringNCT03337802 · lead sponsor · 2017-11-30
COMPLETEDEffects of Nocturnal Hypertension on Sleep Quality in Renal Transplant RecipientsNCT03651492 · lead sponsor · 2017-06-01
UNKNOWNEffects of a Portfolio Diet on NAFLD in Type 2 Diabetic PatientsNCT03380416 · lead sponsor · 2017-04-04
COMPLETEDEffects of Tomato Products in Children With NAFLDNCT03463967 · lead sponsor · 2016-10-01
UNKNOWNThe Effects of Focal Vibration on Spasticity in Multiple Sclerosis PatientsNCT02848898 · lead sponsor · 2016-08-01
UNKNOWNThe Effects of Butyrate on Children With ObesityNCT02721953 · lead sponsor · 2016-03-01
UNKNOWNFiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac DiseaseNCT03380988 · lead sponsor · 2015-11-01
COMPLETEDInterval Training and Hormones in Chronic Heart FailureNCT02322034 · lead sponsor · 2015-01-01
UNKNOWNHormone Deficiency in Heart Failure With Preserved Ejection FractionNCT02976350 · lead sponsor · 2015-01-01
COMPLETEDIncreasing Calcium Dietary Intake Helps to Control Blood Presure and Body WeightNCT02295852 · lead sponsor · 2014-12-01
UNKNOWNDietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic ManifestationsNCT03861910 · lead sponsor · 2014-12-01
COMPLETEDPostprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic OptionsNCT02365740 · lead sponsor · 2014-11-01
UNKNOWNFlavor Test Results in General PopulationNCT03506074 · lead sponsor · 2014-10-01
COMPLETEDMetabolic Effect of New Foods Through Gut-brain AxisNCT01851304 · lead sponsor · 2014-09-01
COMPLETEDDrugs studied in this sponsor's trials
11 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Federico II University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
somatropin5
placebo2
dexamethasone Drug Implant1
ezetimibe Oral Tablet1
faricimab Injection [Vabysmo]1
liraglutide 6 MG/ML [Saxenda]1
metformin1
orlistat1
somatropin RxCUI 61148 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting
5 trials
placebo RxCUI 8375 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting
2 trials
dexamethasone Drug Implant RxCUI 854176 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
ezetimibe Oral Tablet RxCUI 378303 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
faricimab Injection [Vabysmo] RxCUI 2591593 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
liraglutide 6 MG/ML [Saxenda] RxCUI 1598265 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
orlistat RxCUI 37925 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
placebo Oral Tablet RxCUI 375221 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
semaglutide RxCUI 1991302 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
simvastatin Oral Tablet RxCUI 373888 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor85
collaborator25
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.